Similar articles for PMID: 27896639

Year	Number of Results
1935	1
1986	1
1990	1
2002	1
2003	1
2004	3
2006	1
2007	1
2009	2
2010	1
2011	5
2012	21
2013	9
2014	9
2015	9
2016	10
2017	12
2018	10
2019	5
2020	6
2021	3
2022	7
2023	1
2024	0

1

SEOM Clinical Guideline for bone metastases from solid tumours (2016).

Grávalos C, Rodríguez C, Sabino A, Seguí MÁ, Virizuela JA, Carmona A, Cassinello J, Isla D, Jara C, Martín M. Grávalos C, et al. Clin Transl Oncol. 2016 Dec;18(12):1243-1253. doi: 10.1007/s12094-016-1590-1. Epub 2016 Nov 28. Clin Transl Oncol. 2016. PMID: 27896639 Free PMC article.

2

SEOM guidelines for the treatment of bone metastases from solid tumours.

Cassinello Espinosa J, González Del Alba Baamonde A, Rivera Herrero F, Holgado Martín E; SEOM (Spanish Society of Clinical Oncology). Cassinello Espinosa J, et al. Clin Transl Oncol. 2012 Jul;14(7):505-11. doi: 10.1007/s12094-012-0832-0. Clin Transl Oncol. 2012. PMID: 22721794

3

Early identification and intervention matters: A comprehensive review of current evidence and recommendations for the monitoring of bone health in patients with cancer.

Brodowicz T, Hadji P, Niepel D, Diel I. Brodowicz T, et al. Cancer Treat Rev. 2017 Dec;61:23-34. doi: 10.1016/j.ctrv.2017.09.008. Epub 2017 Oct 18. Cancer Treat Rev. 2017. PMID: 29100167 Free article. Review.

4

Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.

Xie J, Namjoshi M, Wu EQ, Parikh K, Diener M, Yu AP, Guo A, Culver KW. Xie J, et al. J Manag Care Pharm. 2011 Oct;17(8):621-43. doi: 10.18553/jmcp.2011.17.8.621. J Manag Care Pharm. 2011. PMID: 21942303 Free PMC article. Clinical Trial.

5

Bisphosphonates and other bone agents for breast cancer.

Wong MH, Stockler MR, Pavlakis N. Wong MH, et al. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003474. doi: 10.1002/14651858.CD003474.pub3. Cochrane Database Syst Rev. 2012. PMID: 22336790 Updated. Review.

6

Advances in prevention and treatment of bone metastases in prostate cancer. Role of RANK/RANKL inhibition.

Gomez-Veiga F, Ponce-Reixa J, Martinez-Breijo S, Planas J, Morote J. Gomez-Veiga F, et al. Actas Urol Esp. 2013 May;37(5):292-304. doi: 10.1016/j.acuro.2012.09.001. Epub 2012 Dec 13. Actas Urol Esp. 2013. PMID: 23246105 Review. English, Spanish.

7

Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options.

Gartrell BA, Coleman R, Efstathiou E, Fizazi K, Logothetis CJ, Smith MR, Sonpavde G, Sartor O, Saad F. Gartrell BA, et al. Eur Urol. 2015 Nov;68(5):850-8. doi: 10.1016/j.eururo.2015.06.039. Epub 2015 Jul 4. Eur Urol. 2015. PMID: 26153564 Review.

8

Optimizing skeletal-related events prevention in patients with advanced prostate cancer.

Leung AK. Leung AK. Asia Pac J Clin Oncol. 2020 Sep;16 Suppl 3:4-6. doi: 10.1111/ajco.13315. Asia Pac J Clin Oncol. 2020. PMID: 32852902

9

Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours.

Zheng GZ, Chang B, Lin FX, Xie D, Hu QX, Yu GY, Du SX, Li XD. Zheng GZ, et al. Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12541. Epub 2016 Jul 19. Eur J Cancer Care (Engl). 2017. PMID: 27430483

10

Bone-targeted agents in the treatment of lung cancer.

Silva SC, Wilson C, Woll PJ. Silva SC, et al. Ther Adv Med Oncol. 2015 Jul;7(4):219-28. doi: 10.1177/1758834015582178. Ther Adv Med Oncol. 2015. PMID: 26136853 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year